Raptor Pharmaceutical's Trial Failed, But Huntington's Disease Update Could Bring Gains At Year End

By: via Benzinga
Raptor Pharmaceutical Corp. (NASDAQ: RPTP) shares have plunged 43 percent in the last month, and are trading close to the lower ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.